These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1614048)

  • 21. Effects of etidronate-mediated suppression of bone remodeling on aluminum-induced de novo bone formation.
    Quarles LD; Drezner MK
    Endocrinology; 1992 Jul; 131(1):122-6. PubMed ID: 1611990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strontium causes osteomalacia in chronic renal failure rats.
    Schrooten I; Cabrera W; Goodman WG; Dauwe S; Lamberts LV; Marynissen R; Dorriné W; De Broe ME; D'Haese PC
    Kidney Int; 1998 Aug; 54(2):448-56. PubMed ID: 9690211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Total allowable concentrations of monomeric inorganic aluminum and hydrated aluminum silicates in drinking water.
    Willhite CC; Ball GL; McLellan CJ
    Crit Rev Toxicol; 2012 May; 42(5):358-442. PubMed ID: 22512666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aluminum intoxication in vitamin D-deficient rats: studies of bone aluminum localization and histomorphometry before and after vitamin D repletion.
    Hodsman AB; Steer BM; Arsenault AL
    J Bone Miner Res; 1988 Aug; 3(4):375-83. PubMed ID: 2851921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aluminum-associated bone disease in chronic renal failure: high prevalence in a long-term dialysis population.
    Andress DL; Maloney NA; Endres DB; Sherrard DJ
    J Bone Miner Res; 1986 Oct; 1(5):391-8. PubMed ID: 3503554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aluminium-induced bone disease in uremic rats: effect of deferoxamine.
    Jablonski G; Klem KH; Danielsen CC; Mosekilde L; Gordeladze JO
    Biosci Rep; 1996 Feb; 16(1):49-63. PubMed ID: 8861540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of bone resulting from accumulation of aluminum in bone of patients undergoing dialysis.
    Faugere MC; Arnala IO; Ritz E; Malluche HH
    J Lab Clin Med; 1986 Jun; 107(6):481-7. PubMed ID: 3486929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Animal model of aluminum-induced osteomalacia: role of chronic renal failure.
    Robertson JA; Felsenfeld AJ; Haygood CC; Wilson P; Clarke C; Llach F
    Kidney Int; 1983 Feb; 23(2):327-35. PubMed ID: 6842959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High fluoride intakes cause osteomalacia and diminished bone strength in rats with renal deficiency.
    Turner CH; Owan I; Brizendine EJ; Zhang W; Wilson ME; Dunipace AJ
    Bone; 1996 Dec; 19(6):595-601. PubMed ID: 8968025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aluminium-induced osteomalacia in severe chronic renal failure (SCRF).
    Visser WJ; Van de Vyver FL
    Clin Nephrol; 1985; 24 Suppl 1():S30-6. PubMed ID: 3915958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-term aluminum administration in the rat: reductions in bone formation without osteomalacia.
    Goodman WG
    J Lab Clin Med; 1984 May; 103(5):749-57. PubMed ID: 6715954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone histologic response to deferoxamine in aluminum-related bone disease.
    Andress DL; Nebeker HG; Ott SM; Endres DB; Alfrey AC; Slatopolsky EA; Coburn JW; Sherrard DJ
    Kidney Int; 1987 Jun; 31(6):1344-50. PubMed ID: 2441107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parenteral aluminum administration in the dog: II. Induction of osteomalacia and effect on vitamin D metabolism.
    Goodman WG; Henry DA; Horst R; Nudelman RK; Alfrey AC; Coburn JW
    Kidney Int; 1984 Feb; 25(2):370-5. PubMed ID: 6547191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time-evolution and reversibility of strontium-induced osteomalacia in chronic renal failure rats.
    Oste L; Bervoets AR; Behets GJ; Dams G; Marijnissen RL; Geryl H; Lamberts LV; Verberckmoes SC; Van Hoof VO; De Broe ME; D'Haese PC
    Kidney Int; 2005 Mar; 67(3):920-30. PubMed ID: 15698431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strontium increases vertebral bone volume in rats at a low dose that does not induce detectable mineralization defect.
    Grynpas MD; Hamilton E; Cheung R; Tsouderos Y; Deloffre P; Hott M; Marie PJ
    Bone; 1996 Mar; 18(3):253-9. PubMed ID: 8703581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Desferrioxamine therapy in hemodialysis patients with aluminum-associated bone disease.
    Felsenfeld AJ; Rodriguez M; Coleman M; Ross D; Llach F
    Kidney Int; 1989 Jun; 35(6):1371-8. PubMed ID: 2770115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Iron lactate-induced osteomalacia in association with osteoblast dynamics.
    Matsushima S; Torii M; Ozaki K; Narama I
    Toxicol Pathol; 2003; 31(6):646-54. PubMed ID: 14585733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A histomorphometric analysis of the effects of fluoride on experimental ectopic bone formation in the rat.
    Mohr H; Kragstrup J
    J Dent Res; 1991 Jun; 70(6):957-60. PubMed ID: 2045575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deferoxamine-induced bone changes in haemodialysis patients: a histomorphometric study.
    Charhon SA; Chavassieux P; Boivin G; Parisien M; Chapuy MC; Traeger J; Meunier PJ
    Clin Sci (Lond); 1987 Aug; 73(2):227-34. PubMed ID: 3652627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aluminum-related bone disease.
    Malluche HH; Faugere MC
    Blood Purif; 1988; 6(1):1-15. PubMed ID: 3345241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.